141 related articles for article (PubMed ID: 8230399)
21. Phenylbutazone blood and urine concentrations, pharmacokinetics, and effects on biomarkers of inflammation in horses following intravenous and oral administration of clinical doses.
Knych HK; Arthur RM; McKemie DS; Seminoff K; Hamamoto-Hardman B; Kass PH
Drug Test Anal; 2019 Jun; 11(6):792-803. PubMed ID: 30499176
[TBL] [Abstract][Full Text] [Related]
22. Population distributions of phenylbutazone and oxyphenbutazone after oral and i.v. dosing in horses.
Chay S; Woods WE; Nugent TE; Weckman T; Houston T; Sprinkle F; Blake JW; Tobin T; Soma LR; Yocum J
J Vet Pharmacol Ther; 1984 Dec; 7(4):265-76. PubMed ID: 6512917
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of phenylbutazone in neonatal foals.
Wilcke JR; Crisman MV; Sams RA; Gerken DF
Am J Vet Res; 1993 Dec; 54(12):2064-7. PubMed ID: 8116939
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of intravenous and intragastric cimetidine in horses. I. Effects of intravenous cimetidine on pharmacokinetics of intravenous phenylbutazone.
Sams RA; Gerken DF; Dyke TM; Reed SM; Ashcraft SM
J Vet Pharmacol Ther; 1997 Oct; 20(5):355-61. PubMed ID: 9350255
[TBL] [Abstract][Full Text] [Related]
25. Phenylbutazone in the horse: a review.
Tobin T; Chay S; Kamerling S; Woods WE; Weckman TJ; Blake JW; Lees P
J Vet Pharmacol Ther; 1986 Mar; 9(1):1-25. PubMed ID: 3517382
[TBL] [Abstract][Full Text] [Related]
26. Solid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds.
Caturla MC; Cusido E
J Chromatogr; 1992 Oct; 581(1):101-7. PubMed ID: 1429991
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration.
Lees P; Ayliffe T; Maitho TE; Taylor JB
Res Vet Sci; 1988 Jan; 44(1):57-67. PubMed ID: 3375589
[TBL] [Abstract][Full Text] [Related]
28. Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses.
Monreal L; Sabaté D; Segura D; Mayós I; Homedes J
Res Vet Sci; 2004 Apr; 76(2):145-9. PubMed ID: 14672858
[TBL] [Abstract][Full Text] [Related]
29. [The concentration changes of different phenylbutazone formulations in horse plasma].
Keller H; Hashem A
Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
[TBL] [Abstract][Full Text] [Related]
30. Effects of top-dress formulations of suxibuzone and phenylbutazone on development of gastric ulcers in horses.
Andrews FM; Reinemeyer CR; Longhofer SL
Vet Ther; 2009; 10(3):113-20. PubMed ID: 20037965
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and anti-inflammatory effects of flunixin meglumine as a sole agent and in combination with phenylbutazone in exercised Thoroughbred horses.
Knych HK; Arthur RM; McKemie DS; Baden RW; Seminoff K; Kass PH
Equine Vet J; 2021 Jan; 53(1):102-116. PubMed ID: 32145701
[TBL] [Abstract][Full Text] [Related]
32. Multicentre, controlled, randomised and blinded field study comparing efficacy of suxibuzone and phenylbutazone in lame horses.
Sabaté D; Homedes J; Salichs M; Sust M; Monreal L
Equine Vet J; 2009 Sep; 41(7):700-5. PubMed ID: 19927590
[TBL] [Abstract][Full Text] [Related]
33. The bioavailability of phenylbutazone in the horse.
Smith PB; Caldwell J; Smith RL; Horner MW; Moss MS
Xenobiotica; 1987 Apr; 17(4):435-43. PubMed ID: 3604253
[TBL] [Abstract][Full Text] [Related]
34. Effects of single-dose intravenous phenylbutazone on experimentally induced, reversible lameness in the horse.
Foreman JH; Barange A; Lawrence LM; Hungerford LL
J Vet Pharmacol Ther; 2008 Feb; 31(1):39-44. PubMed ID: 18177317
[TBL] [Abstract][Full Text] [Related]
35. Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography-mass spectrometry.
Neto LM; Andraus MH; Salvadori MC
J Chromatogr B Biomed Appl; 1996 Apr; 678(2):211-8. PubMed ID: 8738024
[TBL] [Abstract][Full Text] [Related]
36. Effect of an endurance-like exercise on the disposition and detection time of phenylbutazone and dexamethasone in the horse: application to medication control.
Authie EC; Garcia P; Popot MA; Toutain PL; Doucet M
Equine Vet J; 2010 Apr; 42(3):240-7. PubMed ID: 20486981
[TBL] [Abstract][Full Text] [Related]
37. Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.
Soma LR; Sams R; Duer W; Tobin T; Woodward C; McDonald J
Am J Vet Res; 1985 Apr; 46(4):932-8. PubMed ID: 4014842
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic interactions between repeated dose phenylbutazone and gentamicin in the horse.
Whittem T; Firth EC; Hodge H; Turner K
J Vet Pharmacol Ther; 1996 Dec; 19(6):454-9. PubMed ID: 8971674
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous high-performance liquid chromatographic determination of suxibuzone and its metabolites in plasma and urine.
Marunaka T; Shibata T; Minami Y; Umeno Y; Shindo T
J Pharm Sci; 1980 Nov; 69(11):1258-61. PubMed ID: 7452452
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of methocarbamol and phenylbutazone in exercised Thoroughbred horses.
Knych HK; Stanley SD; Seminoff KN; McKemie DS; Kass PH
J Vet Pharmacol Ther; 2016 Oct; 39(5):469-77. PubMed ID: 26924025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
